Prospective screening of liver fibrosis in a primary care cohort using systematic calculation of fib-4 in routine results

Philippe Halfon, Christelle Ansaldi, Guillaume Penaranda, Laurent Chiche, Patrick Dukan, Chloé Stavris, Anne Plauzolles, Frédérique Retornaz, Marc Bourliere
doi: https://doi.org/10.1101/2021.01.13.21249262

Article Information

doi 
https://doi.org/10.1101/2021.01.13.21249262
History 
  • January 15, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Philippe Halfon1,2,*,
  2. Christelle Ansaldi2,
  3. Guillaume Penaranda1,
  4. Laurent Chiche2,
  5. Patrick Dukan2,
  6. Chloé Stavris2,
  7. Anne Plauzolles1,
  8. Frédérique Retornaz2 and
  9. Marc Bourliere3
  1. 1Laboratoire Alphabio
  2. 2Hôpital Européen
  3. 3Hôpital Saint-Joseph, Marseille, FRANCE
  1. ↵*Corresponding Author:
    Pr Philippe HALFON – Laboratoire Alphabio, 1 rue Melchior Guinot, 13003 Marseille – FRANCE – philippe.halfon{at}alphabio.fr
Back to top
Posted January 15, 2021.
Download PDF
Data/Code
Email
Prospective screening of liver fibrosis in a primary care cohort using systematic calculation of fib-4 in routine results
Philippe Halfon, Christelle Ansaldi, Guillaume Penaranda, Laurent Chiche, Patrick Dukan, Chloé Stavris, Anne Plauzolles, Frédérique Retornaz, Marc Bourliere
medRxiv 2021.01.13.21249262; doi: https://doi.org/10.1101/2021.01.13.21249262
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area